🏆 MIT $100K Winner Revolutionizes Drug Delivery: Faster Treatments for Cancer & Autoimmune Diseases

 This year’s MIT $100K Entrepreneurship Competition grand prize went to CoFlo Medical, a startup tackling a critical bottleneck in medicine: slow biologic drug delivery. Their breakthrough device injects viscous drugs 10x faster, freeing patients from hours-long IV sessions.

💉 Why This Matters

  • Current Challenge: Biologic drugs (for cancer, autoimmune diseases, etc.) often require 4–8-hour IV infusions due to high viscosity.

  • CoFlo’s Solution: A dual-fluid system that enables rapid injections (even for honey-thick drugs) without reformulation.

  • Impact: Faster treatment, reduced hospital time, and better access for remote areas.

Quote from Founder Simon Rufer (MIT MechE PhD Candidate):
"Patients shouldn’t be tethered to hospital beds for life-saving treatments. Our technology cuts delivery to minutes—no compromise on safety or cost."


🔬 The Science Behind It

  • Uses a low-viscosity fluid sheath to "lubricate" viscous drugs through needles.

  • Patented tech developed over 6 years at MIT.

  • Lab tests show 200x faster injections than current methods.


🏅 Other $100K Highlights

  1. Haven (Founder’s Prize, $50K): AI platform for lifelong disability care planning.

  2. Aorta Scope (3rd Place, $5K): AR-guided ultrasound for vascular surgery.

  3. Flood Dynamics (Audience Choice): Real-time rain-flood modeling to save cities $30B/year.

#MedTech #Startup #MITInnovation #Biologics #HealthcareAccess

Comments

Popular posts from this blog

Black Coffee = Longer Life? ☕ New Study Reveals the Catch!

🔬 Revolutionary Self-Healing Polymer Breakthrough!

🚀 Exciting Short-Term Course Announcement! 🚀